Thought Leadership
Biosimilar Firms Must Be Ready for US ‘Patent Dance,’ Says IP Lawyer
August 13, 2014
Dan Stanton
BioPharma-Reporter.com

Axinn counsel Stacie Ropka was quoted in Dan Stanton’s article, “Biosimilar Firms Must Be Ready for US ‘Patent Dance,’ Says IP Lawyer,” which appeared on BioPharma-Reporter.com.

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.